OmniAb, Inc. (OABI)

NASDAQ: OABI · Real-Time Price · USD

1.890

-0.110 (-5.50%)

At close: Mar 6, 2026, 4:00 PM EST

1.860

-0.030 (-1.59%)

After-hours: Mar 6, 2026, 6:35 PM EST

OmniAb Employees

OmniAb had 114 employees as of December 31, 2024. The number of employees increased by 8 or 7.55% compared to the previous year.

Employees

114

Change (1Y)

8

Growth (1Y)

7.55%

Revenue / Employee

$163,737

Profits / Employee

-$568,237

Market Cap

273.64M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	114	8	7.55%
Dec 31, 2023	106	11	11.58%
Dec 31, 2022	95	21	28.38%
Sep 30, 2022	93	23	32.86%
Jun 30, 2022	87	17	24.29%
Dec 31, 2021	74	4	5.71%
Sep 30, 2021	70	0	-
Dec 31, 2020	70	-	-

Related Stocks

Company Name	Employees
Cellectis	222
AC Immune	172
Coherus Oncology	158
Abeona Therapeutics	136
Prelude Therapeutics	131
Enlivex	71
Cybin	50
Fennec Pharmaceuticals	32

Employee Rankings

OABI News

1 day ago - OmniAb, Inc. (OABI) Q4 2025 Earnings Call Transcript - Seeking Alpha
2 days ago - OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - Business Wire
10 days ago - OmniAb to Participate at the Leerink Partners Global Healthcare Conference - Business Wire
15 days ago - OmniAb to Report Fourth Quarter 2025 Financial Results on March 4 - Business Wire
2 months ago - OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript - Seeking Alpha
2 months ago - Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies - Business Wire
3 months ago - OmniAb to Hold OmniUltra Virtual Investor Event on December 15 - Business Wire
3 months ago - OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors - Business Wire